Analysis Inozyme Pharma, Inc. (INZY)
6/3/2024
Analysis of Inozyme Pharma, Inc. (INZY)
Inozyme Pharma, Inc. is showing some interesting trends based on the provided data:1. **Price Movement**: The closing prices have been fluctuating between 4.4 and 4.82 over the past few days, indicating some volatility in the stock.
2. **RSI Indicator**: The Relative Strength Index (RSI) values have been hovering around 40-50, suggesting that the stock is neither overbought nor oversold. This indicates a balanced market sentiment.
3. **MACD Indicator**: The Moving Average Convergence Divergence (MACD) values have been negative but showing signs of improvement, with the MACD line getting closer to the signal line. This could indicate a potential bullish momentum building up.
4. **Moving Averages**: The Simple Moving Average (SMA), Exponential Moving Average (EMA), and Weighted Moving Average (WMA) values are all relatively close to each other, indicating a stable trend in the stock price.
5. **Overall**: Inozyme Pharma, Inc. seems to be in a consolidation phase with no clear trend direction. Traders and investors may want to closely monitor the MACD indicator for a potential trend reversal or continuation.
Please note that this analysis is based on historical data and market conditions can change rapidly. It's always recommended to conduct further research or consult with a financial advisor before making any investment decisions.
Balance Sheet
These are balance sheets. Here are the conclusions:1. The total assets have been increasing over the years, reaching $365,725,000,000 in 2018.
2. Current assets have fluctuated, with the highest value in 2019 at $162,819,000,000.
3. Non-current assets have shown an increasing trend, with the highest value in 2019 at $175,697,000,000.
4. Total liabilities have also been increasing, reaching $255,355,000,000 in 2018.
5. Shareholders' equity has shown an increasing trend, with the highest value in 2018 at $107,147,000,000.
6. The company has been relying more on non-current assets to finance its operations, as seen in the increasing trend of non-current assets compared to current assets.
7. The company has been able to maintain a positive shareholders' equity throughout the years, indicating a healthy financial position.
Cash Flow 💶
This is the cash flow statement. Here are some conclusions we can draw from the data:1. The company's free cash flow has been fluctuating over the years, with the highest value in 2022 and the lowest in 2020.
2. Operating cash flow has been consistently higher than free cash flow, indicating that the company is generating sufficient cash from its core operations.
3. The company has been paying a significant amount in income taxes each year, with the highest amount paid in 2021.
4. The end cash position has also varied, with the highest value in 2020 and the lowest in 2022.
5. Financing activities have had a significant impact on the company's cash flow, with large amounts being used for common stock repurchase and debt issuance.
6. Investing activities have also been substantial, with the company making investments through acquisitions and the purchase of investments.
7. Overall, the company seems to be managing its cash flow effectively, with fluctuations in different activities impacting the cash position each year.
Earnings estimate
Based on the analysts' estimates for future quarterly and annual earnings per share:1. For the current quarter ending on June 30, 2024, the average estimated EPS is $1.23, with a low estimate of $1.18 and a high estimate of $1.26. This shows an improvement compared to the EPS of $1.17 from the same quarter a year ago.
2. For the next quarter ending on September 30, 2024, the average estimated EPS is $1.42, with a low estimate of $1.33 and a high estimate of $1.51. This also indicates growth from the EPS of $1.35 in the same quarter last year.
3. Looking at the estimates for the current year ending on September 30, 2024, the average estimated EPS is $6.10, ranging from a low estimate of $5.95 to a high estimate of $6.41. This reflects an increase from the EPS of $5.67 for the previous year.
4. For the next year ending on September 30, 2025, the average estimated EPS is $6.69, with a low estimate of $5.92 and a high estimate of $7.31. This suggests a slight improvement from the EPS of $6.10 in the previous year.
Overall, the analysts' estimates point towards a positive trend of increasing earnings per share for the company in both the short term and the long term.
Revenue estimate
The analysts' estimates for the future quarterly and annual sales of the company indicate a moderate growth trend.For the current quarter ending on June 30, 2024, the average sales estimate is $77,545,400,000, with a sales growth of 2% compared to the same quarter last year. The number of analysts providing estimates is 25.
Looking at the next quarter ending on September 30, 2024, the average sales estimate is $85,501,800,000, showing a sales growth of 3% compared to the previous year's same quarter. The number of analysts providing estimates remains at 25.
For the current fiscal year ending on September 30, 2024, the average sales estimate is $357,772,000,000, with a sales growth of 1% compared to the previous fiscal year. The number of analysts providing estimates is 38.
In the following fiscal year ending on September 30, 2025, the average sales estimate is $380,772,000,000, indicating a more significant sales growth of 6% compared to the current fiscal year. The number of analysts providing estimates remains at 38.
Overall, the estimates suggest a steady growth trajectory for the company's sales in both the short term and the long term.
Growth estimates
Based on the consensus estimates provided, we can draw the following conclusions regarding the growth rate of the company for different periods:1. Current Quarter: The estimated growth rate for the current quarter is 5.1%.
2. Next Quarter: The estimated growth rate for the next quarter is slightly higher at 5.2%.
3. Current Year: The growth rate for the current year is estimated to be 7.6%.
4. Next Year: The growth rate is expected to increase further to 9.7% for the next year.
5. Past 5 Years: Over the past 5 years, the company has shown a growth rate of approximately 20.1% per annum.
6. Next 5 Years: Looking ahead, analysts project a growth rate of around 9.7% per annum for the next 5 years.
These estimates suggest a positive outlook for the company, with a gradual increase in growth rates expected in the upcoming periods compared to the current and past performance.
Price target
The analysts' forecast for the future price of the security paper is as follows:- Low: $164
- High: $275
- Median: $201.43
- Average: $204.58
- Current price: $192.25
Based on these forecasts, it appears that the analysts are generally optimistic about the future price of the security paper, with a median price of $201.43 and an average price of $204.58. However, it's worth noting that there is a wide range of forecasts, from a low of $164 to a high of $275. The current price of the security paper is $192.25.
Earnings
The company's results for the most recent quarter ending on April 30, 2025, have not been provided at this time. The previous results were reported on February 27, 2025, through the Transfer Agent. Before that, on January 31, 2025, the results were released after hours. The results for October 31, 2024, were not provided at the time. On August 1, 2024, the company reported an earnings per share (EPS) estimate of 1.32.Main Statystic ðŸ§
The data provided includes financials, stock statistics, valuation metrics, stock price summary, and dividends and splits information for a specific company.In terms of financials, the company has strong operating cash flow and levered free cash flow, with a positive current ratio. The profit margin and operating margin are also healthy, indicating efficient operations. The company's fiscal year ends in September 2023, and the most recent quarter reported is March 2024. The company shows good returns on assets and equity.
Looking at stock statistics, the company has a low short ratio and a significant percentage of shares held by institutions. The stock price summary shows a beta value, moving averages, and the range of the stock price over the past year.
Valuation metrics indicate the company's price relative to its earnings, book value, and sales. The company's market capitalization and enterprise value are also provided.
Lastly, dividends and splits information includes details about dividend rates, payout ratios, dividend dates, and historical splits. The company has a consistent dividend yield and a history of dividend payments.
Income statement 💸
These are the revenues. Here are the conclusions:1. The company's sales have been increasing steadily over the past four years, from $274.5 billion in 2020 to $383.3 billion in 2023.
2. The gross profit margin has been relatively stable, ranging from 38% to 44% over the same period.
3. Despite the increase in sales, the net income has not shown a consistent upward trend, with fluctuations in the range of $57.4 billion to $98.0 billion.
4. The company has been able to maintain a strong EBITDA margin, hovering around 33% to 35%.
5. The basic and diluted earnings per share (EPS) have also shown some variability, with fluctuations in the range of $3.28 to $6.16.
6. Operating expenses, including research and development, and selling, general, and administrative expenses, have increased over the years, indicating continued investment in the company's operations.
7. The company has managed its non-operating interests and expenses effectively, with a relatively stable trend in this area.
8. Overall, the company's revenue growth has outpaced its net income growth, suggesting potential areas for further cost management or revenue optimization.
MACD of INZY
This is not investment advice. Remember to verify the information provided here.
Get access to the full analysis
- Over 35 000 indexes
- CFD, Forex, Crypto and Stocks Exchange
- Over 150 Indicators
- Pattern and candle analysis
- Support and resistance levels
- Fundamental, technical and sentimental analysis
- Power from AI
